March 2026 · A letter to our angels

Thank you for believing in us.

Since you became our angle investor in August 2025, Pride Health has grown its monthly recurring revenue by 2.5x from $10,500 to $26,800!

We made it happen.

Read more below

We’ve achieved
Product Market Fit.


You bet on our mission, and now it’s validated by a community of > 5,500 users, healthcare partners, and NGO collaborators.


We are ready to accelerate scale and we invite you to join us for this next chapter.

  • SHIELDS Medical Center Bangkok

“We’ve unlocked significant traction by innovating how we communicate our value —

proving that our product & CX design is our competitive & unfair advantage.”

Shawn LOO – Product
01 – our metrics

Our traction and target revenue

$26,780 MRR

a +56% growth vs Feb

Demonstrated strong traction within 12 months of inception. Led by precise execution of PrEP, Doxy & adjacent sexual health categories

$154,803 ARR

Revenue in last 12 months

Monthly revenue continues to grow at CMGR of 23% month on month.

ROAs: 5.5x

Effective spends & optimisation

Driven by a high touch approach. 50% of revenue are from return users and new users CAC of $28

>5,500 users

have registered with pride health

>1,654 prescriptions delivered to 972 users at an ARPU of $170. Our top LTV users ranges from $400 – $2,000 / annum

$100,000 MRR

Our goal by end 2026

and to achieve $ 1 million in annualized revenue in 18 months, driven by new launches of gender affirming, HIV and markets.

Turn Profitable

by end 2026

With monthly trajectory, our $15,000 monthly burn will turn green by end 2026.

02 — What We Can Achieve Together

The foundation is set.
Now it’s time to scale.

We have established our regional GTM playbook with PrEP. Now, we are ready to go deeper into markets with adjacent services.

Now

Sexual Health

$600 million TAM

Grow market share Penetration in our top 3 markets: Singapore, Thailand, Malaysia. Expansion: Korea, Hong Kong

Q3 2026

Gender Affirming Care

$500 Million TAM

Partnering with NGO, Associations, and Community Clinics to capture Mental, HRT pre-op & post-op audience.

Q4 2026

Wellness & Longevity

$300 million TAM

Leverage our telemed stack to capture LGBTQ+ personalised longevity therapies.



180-day Sexual Health.
Growth Roadmap.

Grow Core Engine (PrEP)

  1. 2x active PrEP users
  2. Improve Refill Adherence
  3. 2x subscribers growth

High-Value Bundles

  1. Drive PrEP, Doxy, ED Bundles
  2. Introduce new sexual wellness care i.e Anal Rectal Care

Expand Patient Acquisition

  1. Enable express UX for new users on low-value items i.e. Doxy-PEP
  2. Social content collaboration tags helps drive down CAC.
03 — People

Key Leadership
Additions & Team

Chief Growth

Sukriti Soni joins us starting 1st April 2026.
Sukriti is a senior Life Sciences Commercial leader with 25+ years of experience building and scaling businesses, and delivering high-growth outcomes across global healthcare organizations including J&J, MSD, and Sanofi in APAC.

Chief Tech

Chris Miller joined us since 1st March is a senior tech entrepnurear that has made few exits in his own tech startups. He joins us to lead our tech team for greater agility, AI, Digital Commerce and tech deployments.

04 — The Potential Upside

The exit playbook has been written

February 2026

Eucalyptus — an Australian digital health company built on bundled telehealth subscriptions and direct-to-consumer medications — was acquired by Hims & Hers for up to $1.15 billion USD. Founded in 2019.

A model similar to what Pride Health is building to win in SEA.

The path to acquisition is regional and global players, a very real horizon.

“We are ready to expand our reach, deepen impact and unlock this opportunity…”

Bruce Li — CEO
ticket SIZE / commitment

$15,000

POST money valuation $4 Million



This is an exclusive deal for our existing angels. Your investments will enables us to scale towards a $100,000 MRR by end of 2026 — positioning investment & Pride Health for a 5x valuation .

All investments will be facilitated by A2D or Safe note from us.

Our target is to raise $750k. To date, $150k has already been committed, with an additional $150k in grant funding.

The Founding Team

Built by community,
Creating real impact for LGBTQ+ lives.

Bruce Li

Founder

Shawn Loo

Product

Sukriti Soni

Growth

Dr. Kang Tungsanga

Medical

Chris Miller

Technology

Group portrait of Pride Health's founding team including CEO Bruce Li, seated, with Chris Miller, Shawn Loo, Sukriti Soni and Dr. Kang Tungsanga, united in building inclusive LGBTQ+ healthcare across Southeast Asia

© Pride Health 2026.
Your Health, Our Pride.